Ki‐Hye Kim

1.7k total citations
76 papers, 1.3k citations indexed

About

Ki‐Hye Kim is a scholar working on Epidemiology, Immunology and Infectious Diseases. According to data from OpenAlex, Ki‐Hye Kim has authored 76 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 69 papers in Epidemiology, 45 papers in Immunology and 18 papers in Infectious Diseases. Recurrent topics in Ki‐Hye Kim's work include Respiratory viral infections research (49 papers), Influenza Virus Research Studies (43 papers) and Immune Cell Function and Interaction (32 papers). Ki‐Hye Kim is often cited by papers focused on Respiratory viral infections research (49 papers), Influenza Virus Research Studies (43 papers) and Immune Cell Function and Interaction (32 papers). Ki‐Hye Kim collaborates with scholars based in United States, South Korea and Canada. Ki‐Hye Kim's co-authors include Sang‐Moo Kang, Young‐Tae Lee, Eun‐Ju Ko, Youri Lee, Yu‐Jin Jung, Young‐Man Kwon, Hye Suk Hwang, Yu-Jin Kim, Yuna Lee and Min Chul Kim and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and Journal of Virology.

In The Last Decade

Ki‐Hye Kim

75 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ki‐Hye Kim United States 23 804 526 381 350 125 76 1.3k
Young‐Man Kwon United States 21 798 1.0× 429 0.8× 358 0.9× 317 0.9× 142 1.1× 40 1.2k
Fang Fang China 25 1.2k 1.5× 504 1.0× 466 1.2× 342 1.0× 98 0.8× 70 1.7k
Young‐Tae Lee United States 22 823 1.0× 605 1.2× 378 1.0× 283 0.8× 123 1.0× 54 1.4k
Andreas Grassauer Austria 20 453 0.6× 405 0.8× 280 0.7× 514 1.5× 99 0.8× 28 1.8k
Dae‐Goon Yoo United States 20 356 0.4× 667 1.3× 157 0.4× 348 1.0× 103 0.8× 26 1.4k
Ravi Tandon India 23 499 0.6× 454 0.9× 258 0.7× 362 1.0× 81 0.6× 65 1.6k
Joon‐Yong Bae South Korea 18 291 0.4× 135 0.3× 395 1.0× 209 0.6× 61 0.5× 61 907
Makoto Ohwaki Japan 18 423 0.5× 546 1.0× 199 0.5× 514 1.5× 58 0.5× 36 1.6k
Eun-Ha Kim South Korea 20 553 0.7× 171 0.3× 674 1.8× 239 0.7× 88 0.7× 62 1.2k
Mohsan Ullah Goraya China 15 504 0.6× 416 0.8× 362 1.0× 313 0.9× 26 0.2× 24 1.1k

Countries citing papers authored by Ki‐Hye Kim

Since Specialization
Citations

This map shows the geographic impact of Ki‐Hye Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ki‐Hye Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ki‐Hye Kim more than expected).

Fields of papers citing papers by Ki‐Hye Kim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ki‐Hye Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ki‐Hye Kim. The network helps show where Ki‐Hye Kim may publish in the future.

Co-authorship network of co-authors of Ki‐Hye Kim

This figure shows the co-authorship network connecting the top 25 collaborators of Ki‐Hye Kim. A scholar is included among the top collaborators of Ki‐Hye Kim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ki‐Hye Kim. Ki‐Hye Kim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kim, Ki‐Hye, et al.. (2025). Dual roles of influenza B virus neuraminidase mRNA vaccine in enhancing cross-lineage protection by supplementing inactivated split vaccination. Journal of Virology. 99(5). e0229424–e0229424. 1 indexed citations
2.
Kim, Ki‐Hye, Hye Suk Hwang, Youri Lee, et al.. (2025). Interferon-γ receptor signaling is critical for balanced immune activation and protection against influenza after vaccination. Virology. 612. 110674–110674.
3.
Liu, Rong, Janhavi P. Natekar, Ki‐Hye Kim, et al.. (2024). Multivalent and Sequential Heterologous Spike Protein Vaccinations Effectively Induce Protective Humoral Immunity against SARS-CoV-2 Variants. Vaccines. 12(4). 362–362. 3 indexed citations
5.
Lee, Choon‐Myung, Ki‐Hye Kim, Xiaojia He, et al.. (2023). Metabolic reprograming and increased inflammation by cadmium exposure following early-life respiratory syncytial virus infection: the involvement of protein S-palmitoylation. Toxicological Sciences. 197(2). 186–196. 7 indexed citations
6.
Kim, Ki‐Hye, Subbiah Jeeva, Bo Ryoung Park, et al.. (2023). Heterologous Prime-Boost Vaccination with Inactivated Influenza Viruses Induces More Effective Cross-Protection than Homologous Repeat Vaccination. Vaccines. 11(7). 1209–1209. 6 indexed citations
7.
Jeeva, Subbiah, Ki‐Hye Kim, Chong Hyun Shin, et al.. (2022). A chimeric thermostable M2e and H3 stalk-based universal influenza A virus vaccine. npj Vaccines. 7(1). 68–68. 23 indexed citations
8.
Kim, Ki‐Hye, Chong Hyun Shin, Bo Ryoung Park, et al.. (2022). Thermostable H1 hemagglutinin stem with M2e epitopes provides broad cross-protection against group1 and 2 influenza A viruses. Molecular Therapy — Methods & Clinical Development. 26. 38–51. 5 indexed citations
9.
Jeeva, Subbiah, Ki‐Hye Kim, Bo Ryoung Park, et al.. (2022). Impact of hemagglutination activity and M2e immunity on conferring protection against influenza viruses. Virology. 574. 37–46. 2 indexed citations
10.
Kim, Ki‐Hye, Subbiah Jeeva, Bo Ryoung Park, et al.. (2022). Adjuvant Effects of a New Saponin Analog VSA-1 on Enhancing Homologous and Heterosubtypic Protection by Influenza Virus Vaccination. Vaccines. 10(9). 1383–1383. 5 indexed citations
11.
Kim, Ki‐Hye, Young‐Tae Lee, Eun‐Ju Ko, et al.. (2021). BCG Cell Wall Skeleton As a Vaccine Adjuvant Protects Both Infant and Old-Aged Mice from Influenza Virus Infection. Biomedicines. 9(5). 516–516. 6 indexed citations
12.
Jeeva, Subbiah, Ki‐Hye Kim, Chong Hyun Shin, Bao‐Zhong Wang, & Sang‐Moo Kang. (2021). An Update on mRNA-Based Viral Vaccines. Vaccines. 9(9). 965–965. 23 indexed citations
13.
Kim, Ki‐Hye, Subbiah Jeeva, Bo Ryoung Park, et al.. (2021). Immunogenicity and Neutralizing Activity Comparison of SARS-CoV-2 Spike Full-Length and Subunit Domain Proteins in Young Adult and Old-Aged Mice. Vaccines. 9(4). 316–316. 11 indexed citations
14.
Shin, Chong Hyun, Ki‐Hye Kim, Subbiah Jeeva, & Sang‐Moo Kang. (2021). Towards Goals to Refine Prophylactic and Therapeutic Strategies Against COVID-19 Linked to Aging and Metabolic Syndrome. Cells. 10(6). 1412–1412. 5 indexed citations
18.
Kim, Ki‐Hye, Young‐Tae Lee, Soojin Park, et al.. (2019). Neuraminidase expressing virus-like particle vaccine provides effective cross protection against influenza virus. Virology. 535. 179–188. 52 indexed citations
19.
Kim, Yu-Jin, Eun‐Ju Ko, Min‐Chul Kim, et al.. (2017). Roles of antibodies to influenza A virus hemagglutinin, neuraminidase, and M2e in conferring cross protection. Biochemical and Biophysical Research Communications. 493(1). 393–398. 17 indexed citations
20.
Lee, Young‐Tae, Ki‐Hye Kim, Hye Suk Hwang, et al.. (2015). Innate and adaptive cellular phenotypes contributing to pulmonary disease in mice after respiratory syncytial virus immunization and infection. Virology. 485. 36–46. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026